These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36277293)

  • 41. Hypervascular lesions of the pancreas: Think before you act.
    Wcislak SM; Stiles ZE; Deneve JL; Glazer ES; Behrman SW; Farooq FT; Dickson PV
    Am J Surg; 2019 Aug; 218(2):362-367. PubMed ID: 30509457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of Pancreatic Neuroendocrine Tumors.
    Lee DW; Kim MK; Kim HG
    Clin Endosc; 2017 Nov; 50(6):537-545. PubMed ID: 29207856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 44. Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports.
    Mowrey K; Northrup H; Rougeau P; Hashmi SS; Krueger DA; Ebrahimi-Fakhari D; Towbin AJ; Trout AT; Capal JK; Franz DN; Rodriguez-Buritica D
    Front Neurol; 2021; 12():627672. PubMed ID: 33897589
    [No Abstract]   [Full Text] [Related]  

  • 45. The utility of
    Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
    Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synchronous neuroendocine liver metastases in comparison to primary pancreatic neuroendocrine tumors on MRI and SSR-PET/CT.
    Horng A; Ingenerf M; Berger F; Steffinger D; Rübenthaler J; Zacherl M; Wenter V; Ricke J; Schmid-Tannwald C
    Front Oncol; 2024; 14():1352538. PubMed ID: 38884077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumors.
    Nakashima Y; Ohtsuka T; Nakamura S; Mori Y; Nakata K; Miyasaka Y; Ishigami K; Matsuda R; Oda Y; Nakamura M
    Pancreatology; 2019 Jan; 19(1):50-56. PubMed ID: 30497875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
    Rustagi T; Farrell JJ
    J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
    Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
    Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
    Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.
    Rozenblum L; Mokrane FZ; Yeh R; Sinigaglia M; Besson F; Seban RD; Chougnet CN; Revel-Mouroz P; Zhao B; Otal P; Schwartz LH; Dercle L
    Abdom Radiol (NY); 2019 Jul; 44(7):2474-2493. PubMed ID: 30980115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm.
    Wu L; Zou T; Shi D; Cheng H; Shahbaz M; Umar M; Li T; Zhang X; Gong P; Wei Y
    BMC Endocr Disord; 2022 Oct; 22(1):255. PubMed ID: 36271376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
    Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
    Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M; Brown A; Romero-Hernandez F; Wang JJ; Ganjouei AA; Tozzi F; Rashidian N; Kirkwood K; Corvera C; Nakakura E; Alseidi A; Adam M
    Am J Surg; 2024 Sep; 235():115779. PubMed ID: 38811243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
    Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
    J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid pseudopapillary carcinoma of the pancreas: differentiation from benign solid pseudopapillary tumour using CT and MRI.
    Lee JH; Yu JS; Kim H; Kim JK; Kim TH; Kim KW; Park MS; Kim JH; Kim YB; Park C
    Clin Radiol; 2008 Sep; 63(9):1006-14. PubMed ID: 18718230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.